Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.76
-0.65 (-3.18%)
Mar 27, 2026, 2:15 PM EDT - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $2.24 billion as of March 27, 2026. Its market cap has increased by 213.16% in one year.
Market Cap
2.24B
Enterprise Value
1.66B
1-Year Change
213.16%
Ranking
Category
Stock Price
$19.76
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.24B, an increase of 1,906.91%. That is a compound annual growth rate of 72.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 2.30B | -3.09% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 2.45B |
| Disc Medicine | 2.39B |
| Beam Therapeutics | 2.35B |
| Wave Life Sciences | 2.32B |
| ADMA Biologics | 2.29B |
| Apellis Pharmaceuticals | 2.27B |
| Day One Biopharmaceuticals | 2.21B |
| Adaptive Biotechnologies | 2.18B |